Research Analysts’ downgrades for Saturday, January 27th: Bassett Furniture Industries (NASDAQ:BSET) was downgraded by analysts at StockNews.com from a buy rating to a hold rating. Copa (NYSE:CPA) was downgraded by analysts at StockNews.com from a buy rating to a hold rating. Chesapeake Utilities (NYSE:CPK) was downgraded by analysts at StockNews.com from a hold rating to […]
Significant short covering is observed in Dr Reddy s scrip, with a 4.28 percent surge in the January series future. There is also a notable 3.33 percent decline in cumulative Open Interest (OI) across the current, next, and far series. Call open interest is concentrated at the 6000 and 6100 strikes, while put open interest is prominent at the 5800 strike.
Integrated Health and Wellbeing Council (IHW Council), in collaboration with Dr. Reddy’s Laboratories Limited and Apollo Hospitals, organised a unique ‘Kidney Health Summit 2023’ to address the rising epidemic of chronic kidney diseases in India. The summit witnessed interesting panel discussions on informative topics, led by senior nephrologists, medical practitioners, Government representatives, and industry experts, held virtually.
Shilpa Medicare share jumps 14% on deal for production of Sputnik V vaccine
The targeted production of the dual vector Sputnik V for the first 12 months is 50 million doses (50 million of Component 1 and 50 million of component 2), from the date of start of commercial production
BusinessToday.In | May 17, 2021 | Updated 17:55 IST
Shilpa Medicare share rose 14 per cent to hit an intraday high of Rs 764.45 on BSE today after the company announced that its wholly owned subsidiary Shilpa Biologicals Private Limited (SBPL), has entered into a 3-year definitive agreement with Dr. Reddy s Laboratories Limited (DRL) for production-supply of the Sputnik V vaccine from its integrated biologics R&D cum manufacturing center at Dharwad, Karnataka.